Final Guidance Focuses on Radiolabeled Mass Balance Studies of Investigational Drugs​Regulatory Affairs

Written by

 The FDA has issued a final guidance with recommendations on clinical pharmacology considerations for conducting human radiolabeled mass balance studies, including deciding whether and when to conduct the study, designing the study, and reporting results.

​